Lawrie W. Powell

Brisbane, QLD, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Arthritis Prediction of Advanced Hepatic Fibrosis in HFE Hemochromatosis.

Arthritis Prediction of Advanced Hepatic Fibrosis in HFE Hemochromatosis.

Journal: Mayo Clinic proceedings

Published: June 29, 2021

Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosis.

Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosis.

Journal: Scientific reports

Published: May 13, 2021

Arthropathy in hereditary haemochromatosis segregates with elevated erythrocyte mean corpuscular volume.

Arthropathy in hereditary haemochromatosis segregates with elevated erythrocyte mean corpuscular volume.

Journal: Scandinavian journal of rheumatology

Published: September 18, 2020

Utility of Serum Biomarker Indices for Staging of Hepatic Fibrosis Before and After Venesection in Patients With Hemochromatosis Caused by Variants in HFE.

Utility of Serum Biomarker Indices for Staging of Hepatic Fibrosis Before and After Venesection in Patients With Hemochromatosis Caused by Variants in HFE.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: June 25, 2020

Increased frequency of GNPAT p.D519G in compound HFE p.C282Y/p.H63D heterozygotes with elevated serum ferritin levels.

Increased frequency of GNPAT p.D519G in compound HFE p.C282Y/p.H63D heterozygotes with elevated serum ferritin levels.

Journal: Blood cells, molecules & diseases

Published: May 13, 2020

Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis.

Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis.

Journal: Scientific reports

Published: October 14, 2019

Regression of Fibrosis Stage With Treatment Reduces Long-Term Risk of Liver Cancer in Patients With Hemochromatosis Caused by Mutation in HFE.

Regression of Fibrosis Stage With Treatment Reduces Long-Term Risk of Liver Cancer in Patients With Hemochromatosis Caused by Mutation in HFE.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: July 08, 2019

Detection of HFE Haemochromatosis in the clinic and community using standard erythrocyte tests.

Detection of HFE Haemochromatosis in the clinic and community using standard erythrocyte tests.

Journal: Blood cells, molecules & diseases

Published: September 12, 2018

Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes.

Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes.

Journal: Annals of hepatology

Published: August 27, 2018

Bilirubin acts as a multipotent guardian of cardiovascular integrity: more than just a radical idea.

Bilirubin acts as a multipotent guardian of cardiovascular integrity: more than just a radical idea.

Journal: American journal of physiology. Heart and circulatory physiology

Published: March 31, 2018

Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease.

Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease.

Journal: Blood

Published: February 01, 2018

Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial.

Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial.

Journal: The Lancet. Haematology

Published: September 07, 2017

Showing 1-12 of 33

Last Updated: 09/26/2026